School of Medicine
Showing 241-250 of 2,435 Results
-
Nam Quoc Bui
Clinical Associate Professor, Medicine - Oncology
BioDr. Bui is a Clinical Associate Professor of Medicine at the Stanford Cancer Institute and a specialist in Sarcoma. Dr. Bui earned an undergraduate degree in Computer Science at Stanford University and went on to earn his medical degree from the University of Texas Southwestern Medical Center. He completed Internal Medicine residency at Stanford Hospital and Hematology/Oncology fellowship at the University of California San Diego, where he performed extensive research in bioinformatics to analyze tumor sequencing data.
He is involved in numerous sarcoma clinical trials, leading efforts to take new therapeutics from the lab to clinical practice. His research background and interests are in the field of bioinformatics as applied to large data sets and the study of novel compounds in rare malignancies. He also is involved in education at the Stanford University School of Medicine, serving as a lecturer and mentor to medical students, residents, and oncology fellows. Dr. Bui is the founding Editor-in-Chief of the journal “Current Problems in Cancer: Case Reports”, an international, peer-reviewed journal that publishes groundbreaking cases that give insight into redefining concepts in cancer. He also serves as the Chair of the Data Safety Monitoring Committee at the Stanford Cancer Institute, overseeing the board that reviews all investigator-initiated cancer trials run at Stanford. -
Jeffrey Bunker
Instructor, Medicine - Infectious Diseases
Fellow in Medicine - Med/Infectious DiseasesBioI am a physician-scientist trained in immunology, microbiology, and infectious diseases. I completed an MD and PhD at the University of Chicago, followed by residency in internal medicine and fellowship in infectious diseases at Stanford University. I am currently an Instructor in the Division of Infectious Diseases and Geographic Medicine and a postdoctoral researcher.
My research focuses on adaptive immune responses to microbiota, diet, and pathogens at mucosal surfaces. Dysregulation of these responses is thought to underlie inflammatory bowel diseases, food allergies, celiac disease, and certain infections. My work applies a “specificity-first” approach: by developing tools to resolve lymphocyte antigen receptor specificity at scale, we are interrogating fundamental mechanisms of mucosal tolerance, immunity, and disease, uncovering how specific antigens drive cell fate and function.
I am an active clinician specializing in the diagnosis and management of complex infectious diseases, including antimicrobial-resistant infections and HIV. -
Stephan Busque
Professor of Surgery (Abdominal Transplantation), and by courtesy, of Medicine (Nephrology)
Current Research and Scholarly InterestsMy research interest is focused on the improvement of clinical immunosuppression. I am involved in the evaluation of new immunosuppressive drugs, potentially more efficacious or less toxic. My ultimate goal is to achieve tolerance, a state that would obviate the need for any drugs. I am an investigator part of a multidisciplinary tolerance induction project using total lymphoid irradiation and donor hematopoietic stem cells infusion after living donor kidney transplantation.
-
Rene Caissie
Adjunct Professor, Medicine - Primary Care and Population Health
BioRene Caissie is an entrepreneur, researcher, and former surgeon who holds the position of CEO and Co-Founder at Medeloop.ai, a company dedicated to revolutionizing clinical research and trials through innovative AI technology. He serves as an Adjunct Professor at the Stanford University School of Medicine, where he teaches entrepreneurship in Digital Health and A.I.. In addition, he lectures within the Stanford Master of Science in Clinical Informatics Management (MCIM) program, mentoring students through their practicum experiences. Furthermore, he provides instruction at the Translational Medicine Program (MTM) at UCSF, focusing on the translational challenges in medicine. He is also a member of the XPRIZE Brain Trust Team, where he lends his expertise to foster healthcare innovations. Additionally, Rene serves as a Venture Partner at the venture capitalist firm OVO Fund
Rene’s entrepreneurial and medical expertise has spurred the creation of several healthcare ventures, such as Medesync EMR, which was acquired by the $37 billion telecommunications giant, Telus. Amid the Covid-19 crisis, he played a crucial role in developing a powered Full Head Protective Hood with an air-purifying respirator and co-founding Dorma Filtration, which introduced Canada's first reusable N95 mask.
Beyond his professional pursuits, Rene is an avid mountain climber, sailboat trans-oceanic racer, SR22 Turbo aircraft pilot, and Ironman World Championship qualifier. His dedication to humanitarian work is evident through his NGO, Volte-Face, which has provided over $1 million in free medical care for life-changing surgeries to underprivileged patients. As a board member for Sprouts, a California-based non-profit, he supports disadvantaged youths through skills coaching and internships. -
Jillian Caldwell
Instructor, Medicine - Nephrology
BioJillian S. Caldwell, DO, MS, is a nephrologist and health policy researcher whose work examines how insurance design, health policy, and structural factors influence access to care and outcomes for patients with kidney disease, particularly those receiving maintenance dialysis.
Her research integrates large administrative datasets and quasi-experimental methods to evaluate the effects of policies within Medicare, including the growth of Medicare Advantage and drug payment reforms. She has conducted work examining medication access, dialysis facility practice patterns, and kidney transplantation.
Dr. Caldwell's research has been supported by the American Kidney Fund and the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. She is involved in nephrology policy and advocacy efforts through the American Society of Nephrology. Her long-term goal is to generate evidence that informs policies and delivery system reforms to improve outcomes for people living with kidney disease.